Business: Johnson & Johnson to buy Aragon for up to $1 billion

Source: Reuters

- Last modified: June 17, 2013 at 9:22 AM

Back to Top Comments Print

(Reuters) - Johnson & Johnson said on Monday that it would buy Aragon Pharmaceuticals, a private company that is running a mid-stage clinical trial for a prostate cancer drug, for $650 million in cash upfront and a possible second payment of $350 million if it meets certain milestones.

Continue reading

advertisement

Advanced search
Sponsored by
advertisement
  
  
advertisement
  
  
advertisement
Back to Top